Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q2 EPS

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($0.46), in-line with the analyst estimate of ($0.46).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight
• Midera Food Processing and Centrus Energy to join S&P SmallCap 600